Reach Us +44 1704 335730
Jay Wimalasena | OMICS International
ISSN: 2167-0943

Journal of Metabolic Syndrome
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Relevant Topics

Jay Wimalasena

Jay Wimalasena Jay Wimalasena  Professor University of Tennessee Medical Center USA  


 Jay Wimalasena is Professor & Director of Department of Ob/Gyn . He completed his PhD in Pharmacology from the University of Colorado Medical School, Denver, Colorado He have worked with various association and member of various reputed organisation. He enjoys family-life, reading, writing, music, basketball and golf.He is currently studying: (1) the molecular mechanisms of regulation of the breast cancer cell cycle by estrogens (including myco/phytoestrogens) specifically the regulation of Cdc25A, Cdk inhibitor p27 kip independently of G1 transit; (2) Apoptosis induction by paclitaxel etc. and the anti-apoptotic effects of Estradiol in breast and ovarian cancer cells at the molecular level. Elucidation of the role of Ras, PI-3K, ERK, AKT pathways in estrogen action on cell division and apoptosis.

Research Interest

Breast and Ovarian Cancer, Cell Cycle, CDK, Cyclins, CDK Inhibitors, Apoptosis, Signal Transduction


Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7